ThinkEquity Starts NuVasive (NUVA), OraSure (OSUR), Stereotaxis (STXS), Natus (BABY) at Buy

In the Medical Equipment & Supplies sector Friday morning, an analyst at ThinkEquity initiated coverage on the following stocks, each with Buy ratings:

• NuVasive (Nasdaq: NUVA) - $39 price target
  
• OraSure (Nasdaq: OSUR) - $11 price target
  
• Stereotaxis (Nasdaq: STXS) - $6 price target
  
• Natus Medical (Nasdaq: BABY) - $22 price target

Check out our Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Needham Starts Faeth Therapeutics (FTH) at Buy
• Keefe, Bruyette & Woods Resumes Canadian Imperial Bank of Commerce (CM:CN) (CM) at Market Perform
• BNP Paribas Exane Starts NIQ Global Intelligence Plc (NIQ) at Outperform